"The UK's inability to retain economic benefits of its R&D is a fatal flaw to any growth strategy," according to the document ...

Market observers are closely monitoring potential developments in discussions between Eli Lilly and the Trump administration. Reports indicate the company may be nearing a landmark agreement that ...

Comments from medicines firm Eli Lilly will be a blow to British officials, who are in advanced negotiations with the Trump ...

Eli Lilly, the American pharmaceutical giant, has made two significant announcements that could substantially impact its market position and future growth tr ...

In today’s Pharmaceutical Executive Daily, we cover Pfizer’s lawsuits against Metsera and Novo Nordisk over alleged ...

Lake City Bank is pleased to announce that Trenton H. Cooper has been promoted to Assistant Vice President, Commercial ...

US pharma major Eli Lilly has revealed plans to build a new $3 billion manufacturing facility in Katwijk, the Netherlands, ...

Indianapolis-based Eli Lilly and Company announced Monday, Nov. 3 that it plans to build a new $3 billion manufacturing ...

American pharmaceutical company Eli Lilly plans to build a $3bn manufacturing facility at the Leiden Bio Science Park in ...

Pharmaceutical giant Eli Lilly is demonstrating exceptional market performance, propelled by quarterly results that shattered expectations and a multi-billion dollar expansion initiative. The company ...

The facility will be built in the Netherlands and will increase capacity for the company's oral medicines portfolio ...

Pharmaceutical maker Eli Lilly (LLY +1.13%) has seen its share price rocket higher by over 500% over the past five years.